Clinical Trials List
2007-05-10 - 2017-12-31
Phase III
Terminated7
ICD-10Z41.8
Encounter for other procedures for purposes other than remedying health state
ICD-9V07.2
Prophylactic immunotherapy
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 張逸良 Division of Others
- 李元麒 Division of Thoracic Surgery
- 黃培銘 Division of Thoracic Surgery
- Chong-Jen Yu Division of Thoracic Medicine
- JIN-YUAN SHIH Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Han-Shui Hsu Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 鍾聿修 Division of Thoracic Medicine
- Chao Yin-Kai Division of Thoracic Surgery
- 謝敏暲 Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Ting Yen Division of Thoracic Surgery
- Yau-Lin Tseng Division of Thoracic Surgery
- Wu-Chou Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Pin-Ru Chen Division of Thoracic Surgery
- 方信元 Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
2270 participants
